Armata Pharmaceuticals, Inc. Share Price
ARMPArmata Pharmaceuticals, Inc. Stock Performance
Open $4.66 | Prev. Close $4.52 | Circuit Range N/A |
Day Range $4.66 - $5.29 | Year Range $2.42 - $16.34 | Volume 20,454 |
Average Traded $5.04 |
Armata Pharmaceuticals, Inc. Share Price Chart
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Armata Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-Jul-26 | $4.66 | $5.07 | +0.00% |
20-Jul-26 | $4.66 | $5.07 | +12.17% |
17-Jul-26 | $3.81 | $4.52 | +17.40% |
16-Jul-26 | $3.96 | $3.85 | -3.51% |
15-Jul-26 | $4.00 | $3.99 | +0.50% |
14-Jul-26 | $3.88 | $3.97 | -0.13% |
13-Jul-26 | $4.25 | $3.98 | -6.14% |